Psychiatric care · Ridgeland · Madison · Mississippi

The journal · Mental Health & Wellness

Menopause, Hormones, and Mental Health: Can Hormone Replacement Therapy Help?

Why perimenopause and menopause can change mood, sleep, anxiety, and concentration — what estrogen, progesterone, and GABA have to do with it, what recent research says about hormone therapy, and when psychiatric care is the right next step.

Menopause, Hormones, and Mental Health: Can Hormone Replacement Therapy Help?

Mental Health & Wellness · September 22, 2026

For many women, menopause is associated with hot flashes, night sweats, and changes in the menstrual cycle. What is discussed far less often is what can happen to the brain and mental health during this transition.

A woman who has never struggled significantly with her mental health may suddenly find herself wondering:

  • "Why am I anxious all the time?"
  • "Why can't I sleep anymore?"
  • "Why am I so irritable?"
  • "Why can't I concentrate like I used to?"
  • "Why don't I feel like myself?"

These symptoms are real, and there are biological reasons they can occur.

Estrogen and progesterone do much more than regulate reproduction. These hormones interact with brain systems involved in serotonin, dopamine, GABA, sleep, stress regulation, cognition, memory, and emotional processing. As reproductive hormones fluctuate during perimenopause and ultimately decline following menopause, susceptible women may experience significant changes in mood and cognitive functioning (The Menopause Society, n.d.-a).

Emerging research also suggests that menopausal hormone therapy (MHT), traditionally called hormone replacement therapy or HRT, may improve certain psychological symptoms in appropriately selected women, although hormone therapy should not be viewed as a universal treatment for depression or anxiety.

What Is Menopause?

Menopause is clinically recognized after a woman has gone 12 consecutive months without a menstrual period, assuming there is no other medical explanation.

The years leading up to menopause are known as perimenopause. During this period, ovarian hormone production becomes increasingly variable.

After menopause occurs, a woman is considered postmenopausal.

Although reproductive hormone concentrations eventually become more stable, symptoms can continue for years after the final menstrual period.

Common menopausal symptoms include hot flashes, night sweats, sleep disturbances, genitourinary symptoms, sexual difficulties, and changes in mood (National Institute for Health and Care Excellence [NICE], 2024).

Menopause Can Affect Mental Health

Some women experience significant psychiatric or cognitive symptoms during perimenopause and the early postmenopausal years.

Symptoms may include:

  • Depression or persistent sadness
  • Loss of interest or pleasure
  • Anxiety
  • Panic symptoms
  • Irritability
  • Emotional sensitivity
  • Mood swings
  • Feeling overwhelmed
  • Reduced stress tolerance
  • Insomnia
  • Frequent nighttime awakening
  • Fatigue
  • Difficulty concentrating
  • Forgetfulness
  • Word-finding difficulties
  • "Brain fog"
  • Reduced motivation
  • Changes in libido
  • Problems with attention or executive functioning

The Menopause Society notes that difficulties with concentration and memory are common during the menopause transition and the years immediately following menopause, and that mood and sleep disturbances can further influence cognitive functioning (The Menopause Society, n.d.-a).

For some women, these symptoms are mild. For others, they can interfere with careers, relationships, parenting, sleep, and overall quality of life.

What Is This Phenomenon Called?

There is not currently a single DSM-5-TR psychiatric diagnosis called "postmenopausal depression."

Instead, clinicians and researchers may describe these experiences using terms such as:

  • Menopause-associated mood symptoms
  • Menopause-related depressive symptoms
  • Perimenopausal depression
  • Menopause-associated anxiety
  • Menopause-related cognitive symptoms

One particularly useful concept is the "window of vulnerability."

Research suggests that some women may be particularly sensitive to fluctuations in reproductive hormones. This vulnerability appears especially important during the menopausal transition and early postmenopausal period. Women with a previous history of depression may also be particularly vulnerable (The Menopause Society, n.d.-a).

However, menopause does not exclude the possibility that an independent psychiatric disorder is occurring.

A woman can simultaneously experience menopausal symptoms and major depressive disorder, generalized anxiety disorder, panic disorder, ADHD, bipolar disorder, PTSD, or insomnia disorder.

That distinction is one reason a comprehensive psychiatric assessment can be so valuable.

What Is Actually Happening in the Brain?

Estrogen is much more than a reproductive hormone.

Estrogen receptors are distributed throughout the brain, including regions involved in mood, memory, stress responses, temperature regulation, and cognitive processing (The Menopause Society, n.d.-a).

Several interconnected biological processes may therefore contribute to mental-health changes during menopause.

Estrogen and Serotonin

Serotonin is involved in mood, anxiety, emotional regulation, sleep, appetite, and the stress response.

Estrogen interacts with serotonergic neurotransmission. Consequently, substantial changes in estrogen signaling during the menopausal transition may influence serotonin-related pathways and contribute to depressive symptoms, anxiety, and emotional changes in susceptible individuals.

Estrogen and Dopamine

Dopamine contributes to motivation, reward, attention, concentration, executive functioning, and cognitive processing.

Changes in ovarian hormones may therefore contribute to some of the cognitive complaints women commonly describe as "menopause brain fog."

Some of these symptoms can resemble ADHD. This does not necessarily mean that menopause suddenly caused ADHD. Instead, hormonal changes, sleep disruption, depression, anxiety, or previously compensated attention difficulties may become more noticeable.

Progesterone, Allopregnanolone, and GABA

Progesterone can be metabolized into the neuroactive steroid allopregnanolone.

Allopregnanolone interacts with GABA-A receptors. GABA is one of the brain's major inhibitory neurotransmitters and plays an important role in regulating neuronal excitability.

Changes involving progesterone and its neuroactive metabolites may therefore influence anxiety, sleep, irritability, stress responses, and emotional regulation.

The relationship between reproductive hormones and neurotransmitter systems helps explain why menopause can affect considerably more than the reproductive system.

The Sleep Connection

There is another important pathway that should not be overlooked.

Hot flashes lead to night sweats, which lead to repeated awakenings, sleep deprivation, fatigue, impaired concentration, irritability, and worsening anxiety and depression.

A woman who repeatedly awakens throughout the night may understandably begin experiencing significant changes in mood, cognition, energy, and stress tolerance.

Hormone therapy is considered the most effective treatment for menopausal vasomotor symptoms, including hot flashes and night sweats (The Menopause Society, n.d.-b). Therefore, improving vasomotor symptoms may indirectly improve sleep, daytime functioning, and quality of life.

What Does Recent Research Say About HRT and Mental Health?

Recent research has provided encouraging—but appropriately nuanced—evidence regarding hormone therapy and psychological symptoms.

2026: Meta-Analysis of More Than 41,000 Women

A 2026 systematic review and meta-analysis examined 51 randomized controlled trials involving 41,821 women receiving hormone therapy.

The investigators found that hormone therapy was associated with improvements in several psychological outcomes, including mood and anxiety symptoms, although benefits differed depending upon the outcome and patient population. Postmenopausal women demonstrated particularly notable improvements in sleep quality in the analysis (Frontiers in Medicine, 2026).

This large analysis is important because randomized controlled trials provide substantially stronger evidence than anecdotal reports that women simply "feel better" after starting hormone therapy.

However, the authors also emphasized limitations in the available evidence. Hormone therapy should therefore not be interpreted as a universal treatment for psychiatric illness (Frontiers in Medicine, 2026).

2026: Real-World Hormone Therapy Study

A 2026 observational study examined approximately 260 women receiving systemic hormone therapy.

The percentage experiencing severe mood symptoms reportedly decreased from approximately 62.3% before treatment to 24.6% following treatment. Improvements in psychological and sleep symptoms were observed even after accounting for factors such as psychiatric history and antidepressant use (The Menopause Society, 2026).

These findings are clinically interesting because they reflect patients treated in a real-world environment rather than exclusively under tightly controlled research conditions.

However, because the study was observational rather than a randomized clinical trial, it cannot prove that hormone therapy alone caused the improvements.

2024: Hormone Therapy and Depression

Research presented through The Menopause Society in 2024 examined 170 women attending a specialized menopause clinic and found a substantial prevalence of depressive symptoms.

Improvement in depressive symptoms was reported among women receiving hormone therapy, including some women receiving both hormone therapy and antidepressant treatment (The Menopause Society, 2024).

This raises an important point: treating menopause and treating depression do not necessarily have to be competing approaches. For some patients, both conditions may need to be addressed simultaneously.

What About Anxiety?

The evidence regarding anxiety is more complicated.

A systematic review discussed by The Menopause Society found that hormone therapy may reduce anxiety in some women during perimenopause and early postmenopause, but benefits have not been consistent across all studies. Outcomes may depend on hormone formulation, dose, route of administration, menopausal stage, and individual patient characteristics (The Menopause Society, 2025).

Therefore, severe or persistent anxiety should not automatically be attributed to estrogen deficiency. It deserves a comprehensive assessment.

Is Hormone Replacement Therapy an Antidepressant?

No. This distinction is extremely important.

Hormone therapy should not automatically replace evidence-based psychiatric treatment when a patient has major depressive disorder, an anxiety disorder, bipolar disorder, or another psychiatric illness.

Current NICE menopause guidelines recommend considering HRT for depressive symptoms associated with menopause that do not meet diagnostic criteria for depression, particularly when those symptoms began around the same time as other menopause-associated symptoms (NICE, 2024).

When someone meets diagnostic criteria for clinical depression, depression should be treated according to established evidence-based recommendations while menopausal symptoms are addressed simultaneously (NICE, 2024).

For some women, therefore, the treatment strategy may involve menopause treatment, psychiatric treatment, psychotherapy, sleep treatment, and lifestyle interventions together — rather than choosing between psychiatric care and hormone therapy.

How Are Menopause-Associated Mental Health Symptoms Diagnosed?

There is no single laboratory test that can determine, "Your depression is caused by menopause." Instead, clinicians need to examine the entire clinical picture.

Menopause History

An evaluation may consider:

  • When was the patient's last menstrual period?
  • When did psychiatric symptoms begin?
  • Did symptoms begin during perimenopause?
  • Did symptoms become worse after menopause?
  • Are hot flashes occurring?
  • Are night sweats disrupting sleep?
  • Did symptoms follow hysterectomy or removal of the ovaries?
  • Are sexual or genitourinary symptoms present?

Psychiatric Evaluation

A comprehensive psychiatric evaluation may assess depression, anxiety, panic, sleep, trauma, attention, cognition, substance use, bipolar-spectrum symptoms, and suicide risk.

Standardized screening instruments may include tools such as the PHQ-9, GAD-7, MDQ, ADHD screening measures, and insomnia assessments when clinically appropriate.

Medical Evaluation

It is equally important to remember that other medical problems can mimic or exacerbate psychiatric symptoms. Depending upon the patient's presentation, evaluation may include consideration of:

  • Thyroid dysfunction
  • Anemia
  • Vitamin B12 or folate deficiency
  • Sleep apnea
  • Medication adverse effects
  • Substance use
  • Chronic pain
  • Metabolic disorders
  • Neurologic disease

Menopause itself is frequently diagnosed clinically rather than solely through hormone testing. NICE specifically advises against routinely using several laboratory tests to identify menopause in otherwise healthy women aged 45 or older who have typical menopausal symptoms (NICE, 2024).

What Treatments Are Available?

Treatment should be individualized rather than based solely on a patient's age or hormone level.

1. Menopausal Hormone Therapy

Menopausal hormone therapy generally involves replacing estrogen that has declined during the menopausal transition. Systemic estrogen can be administered through transdermal patches, gels, sprays, or oral preparations.

Women who retain their uterus generally require estrogen combined with an appropriate progestogen to protect the endometrium, whereas estrogen-only therapy is generally used following total hysterectomy (NICE, 2024).

Hormone therapy remains the most effective treatment for menopausal vasomotor symptoms, including hot flashes and night sweats (The Menopause Society, n.d.-b).

2. Antidepressants and Other Psychiatric Medications

When major depression, an anxiety disorder, panic disorder, ADHD, insomnia, bipolar disorder, or another psychiatric condition is present, psychiatric treatment may be appropriate.

SSRIs and SNRIs are commonly used for depression and anxiety, and certain medications within these classes can additionally reduce vasomotor symptoms.

Medication selection should consider the patient's diagnosis, symptoms, medical history, previous treatment responses, concurrent medications, adverse-effect profile, and individual risks.

3. Cognitive Behavioral Therapy

Psychotherapy can also play an important role. Cognitive behavioral therapy may help address depression, anxiety, insomnia, stress, and adjustment to menopause.

NICE recommends considering menopause-specific CBT for depressive symptoms and sleep problems associated with menopause (NICE, 2024).

A recent systematic review also evaluated cognitive-behavioral, acceptance-based, and mindfulness-based interventions for psychological and sleep-related symptoms during menopause, reflecting increasing interest in psychological interventions as part of comprehensive menopause care (de Dios Tapia et al., 2026).

4. Treat Sleep

Sleep should not be treated as an afterthought. Addressing insomnia, night sweats, obstructive sleep apnea, restless legs syndrome, or other sleep disorders can potentially improve daytime energy, concentration, emotional regulation, anxiety, and mood.

5. Lifestyle and Overall Medical Health

Regular physical activity, adequate sleep, healthy nutrition, social engagement, limiting excessive alcohol consumption, smoking cessation, and appropriate management of cardiovascular and metabolic risk factors are also important components of healthy aging and mental health (The Menopause Society, n.d.-a).

Is Hormone Therapy Safe for Everyone?

No. Hormone therapy requires an individualized medical risk-benefit assessment.

Factors such as age, years since menopause, cardiovascular health, history of blood clots, cancer history, liver disease, unexplained vaginal bleeding, and whether the uterus is present can significantly influence treatment decisions.

The Menopause Society indicates that for many healthy symptomatic women, the benefit-risk profile of systemic hormone therapy is generally favorable when therapy is initiated before age 60 or within approximately 10 years of menopause onset, although treatment must still be individualized (The Menopause Society, n.d.-b).

Hormone therapy should therefore not be started simply because someone believes depression, anxiety, or brain fog is caused by estrogen deficiency.

How Can Turned Leaf Psychiatry Help?

One of the most frustrating aspects of menopause-related mental health symptoms is determining where hormonal symptoms end and psychiatric symptoms begin.

At Turned Leaf Psychiatry, we believe women experiencing these changes deserve a comprehensive evaluation rather than having their symptoms dismissed as "it's just menopause."

At the same time, a woman experiencing new depression, anxiety, insomnia, or cognitive difficulties should not automatically assume that hormones are the only explanation.

Turned Leaf Psychiatry can help evaluate whether symptoms may represent:

  • Menopause-associated mood symptoms
  • Major depressive disorder
  • Generalized anxiety or panic disorder
  • ADHD or worsening attention difficulties
  • Insomnia
  • Bipolar-spectrum illness
  • Trauma-related symptoms
  • Medication effects
  • Medical contributors
  • Or a combination of several factors

When clinically appropriate, treatment may include psychiatric medication management, psychotherapy recommendations, sleep interventions, appropriate medical evaluation, and coordination with a patient's primary-care provider, OB/GYN, or menopause specialist regarding menopausal hormone therapy. Our clinic also offers hormone replacement therapy as part of integrated care.

Treat the Person, Not Just the Hormone Level

Menopause represents a major biological transition, but women should not have to assume that significant depression, anxiety, insomnia, irritability, or cognitive difficulties are simply an unavoidable part of aging.

For the right patient, hormone therapy may represent one component of treatment. For another patient, the primary issue may be depression, anxiety, ADHD, insomnia, or another condition requiring psychiatric treatment.

For many women, the most effective approach may involve women's health and psychiatric care working together.

Are You Experiencing Mental Health Changes During or After Menopause?

If you have noticed significant changes in your mood, anxiety, sleep, concentration, motivation, memory, or emotional health during perimenopause or after menopause, consider scheduling a comprehensive psychiatric evaluation with Turned Leaf Psychiatry.

Our goal is to determine not simply what you're experiencing, but why you're experiencing it—and develop an individualized treatment plan designed around you.

Medical disclaimer: This article is provided for educational purposes and should not be considered individualized medical advice. Menopausal hormone therapy and psychiatric medications have potential benefits, risks, contraindications, and drug interactions. Hormone therapy should be prescribed only after an individualized assessment by an appropriately qualified healthcare professional. Seek immediate medical attention for suicidal thoughts or other psychiatric or medical emergencies.

If you are in crisis

If you are having thoughts of suicide or are in emotional crisis, call or text 988 to reach the 988 Suicide & Crisis Lifeline. If you or someone else is in immediate danger, call 911.

Medical disclaimer

This article is educational information only. It is not a diagnosis, a treatment plan, or a substitute for individualized care from your own clinician. For emergencies call 911; for a mental health crisis call or text 988.

Read our editorial policy or report a correction.

Ready when you are

Ready to turn over a new leaf?

Request an appointment with our Ridgeland, Mississippi team.